Abstract:Systemic lupus erythematosus (SLE, OMIM 152700) is a rare autoimmune disease with high heritability that affects ~0.1% of the population. Previous studies have revealed several common variants with small effects in European and East Asian SLE patients. However, there is still no rare variant study on Chinese SLE patients using the whole-genome sequencing technology (WGS). Here, we designed a family based WGS study to identify novel rare variants with large effects. Based on large-scale allele frequency data from the gnomAD database, we identified rare protein-coding gene variants with disruptive and sequence-altering impacts in SLE patients. We found that the burden of rare variants was significantly higher than that of common variants in patients, suggesting a larger effect of rare variants on the SLE pathogenesis. We identified the pathogenic risk of rare missense variants with significant odds ratios (p < 0.05) in two genes, including WNT16 (NC_000007.14:g.121329757G > C, NP_057171.2:p.(Ala86Pro) and 7 g.121329760G > C, NP_057171.2:p.(Ala87Pro)), which explains five out of seven patients covering all three families but are absent from all controls, and ERVW-1 (NC_000007.14:g.92469882A > G, NP_001124397.1:p.(Leu167Pro), rs74545114; NC_000007.14:g.92469907G > A, NP_001124397.1:p.(Arg159Cys), rs201142302; NC_000007.14:g.92469919G > A, NP_001124397.1:p.(His155Tyr), rs199552228), which explains the other two patients. None of these variants were identified in any of the controls. These associations are supported by known gene expression studies in SLE patients based on literature review. We further tested the wild and mutant types using the luciferase assays and qPCR in cells. We found that WNT16 can activate the canonical Wnt/β-catenin pathway while the mutant cannot. Additionally, the wild ERVW-1 expression can be significantly up-regulated by cAMP while the mutant cannot. Our study provides the first direct genetic and in vitro evidence for the pathogenic risk of mutant WNT16 and ERVW-1, which may facilitate the design of precision therapy for SLE.

Two rare UNC93B1 variants contribute to childhood-onset lupus

Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus

UNCovering new causes of monogenic systemic lupus erythematosus

UNC93B1 variants underlie TLR7-dependent autoimmunity

A novel UNC93B1 gain-of-function mutation leads to TLR7 and TLR8 hyperactivation and systemic lupus erythematosus

The emergence of SLE-causing UNC93B1 variants in 2024

Genetic approach to study lupus glomerulonephritis.

A Rare Variant (rs933717) at FBXO31‐MAP1LC3B in Chinese is Associated with Systemic Lupus Erythematosus

Human SLE Variant NCF1-R90H Promotes Kidney Damage and Murine Lupus Through Enhanced Tfh2 Responses Induced by Defective Efferocytosis of Macrophages

Combination of Multiple Genes from Lupus and Diabetes Prone Mice Leads to a Novel Mouse Model for Lupus

Toll-like receptors revisited; a possible role for TLR1 in lupus nephritis

Association of a Common Complement Receptor 2 Haplotype with Increased Risk of Systemic Lupus Erythematosus

Genetic Complementation Results in Augmented Autoantibody Responses to Lupus-Associated Antigens.

Whole-genome sequencing identifies rare missense variants of WNT16 and ERVW-1 causing the systemic lupus erythematosus

Contribution of Genetic Variants associated with Primary Immunodeficiencies to Childhood-Onset Systemic Lupus Erythematous

P2RY8 Variants in Lupus Patients Uncover a Role for the Receptor in Immunological Tolerance

Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus

Current Advances in the Human Lupus Genetics.

Unc93B1 Biases Toll-like Receptor Responses to Nucleic Acid in Dendritic Cells Toward DNA- but Against RNA-sensing.

Rare genetic variants provide a mechanistic basis for immune imbalance in IgG4-related disease

Genetically Determined Aberrant Down-Regulation of FcgammaRIIB1 in Germinal Center B Cells Associated with Hyper-Igg and IgG Autoantibodies in Murine Systemic Lupus Erythematosus.